K. Joko

Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation

Y. Shimizu, J. Tani, H. Toyoda, 2017, Molecular and clinical oncology.

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis

M. Kudo, Y. Hiasa, T. Ishikawa, 2017, Digestive Diseases.

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.

M. Kurosaki, N. Izumi, H. Marusawa, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy

M. Kurosaki, N. Izumi, H. Marusawa, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Small hepatocellular carcinoma associated with Wilson's disease.

M. Abe, N. Horiike, M. Onji, 2005, Internal medicine.

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

M. Kudo, Y. Hiasa, J. Tani, 2021, Scientific Reports.

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response

M. Kurosaki, N. Izumi, H. Marusawa, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting

M. Kudo, Y. Hiasa, J. Tani, 2020, Journal of gastroenterology and hepatology.

Recurrence of hepatitis-associated aplastic anemia after a 10-year interval.

E. Takeshita, T. Muta, T. Fujisaki, 2008, Internal medicine.

Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic

Y. Hiasa, T. Ishikawa, A. Deguchi, 2019, Journal of gastroenterology and hepatology.

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis

Y. Shimizu, J. Tani, H. Toyoda, 2017, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Metastasis from Renal Cell Carcinoma to Ectopic Pancreas Diagnosed after Resection

H. Ochi, Toshie Mashiba, T. Yokota, 2022, Internal medicine.

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

T. Kumada, M. Hirooka, A. Hiraoka, 2021, Clinical radiology.

A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade

Y. Hiasa, T. Ishikawa, K. Nouso, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.